Cargando…
Oncoprotein LAMTOR5 Activates GLUT1 Via Upregulating NF-κB in Liver Cancer
OBJECTIVE: Accumulating reports reveal that serving as an oncogenic factor LAMTOR5 is involved in the progression of many specific cancers. Glucose transporter 1 (GLUT1) is frequently identified in many cancers. However, it remains unexplored whether GLUT1 plays a role in LAMTOR5-enhanced liver canc...
Autores principales: | Zhou, Jing, Li, Yajun, Li, Danhua, Liu, Zhi, Zhang, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6401392/ https://www.ncbi.nlm.nih.gov/pubmed/30847404 http://dx.doi.org/10.1515/med-2019-0022 |
Ejemplares similares
-
NF-κB activation by the viral oncoprotein StpC is enhanced by ERK-mediated p52 and RelB upregulation
por: Katsch, K, et al.
Publicado: (2009) -
Polymorphisms in the Gene Regions of the Adaptor Complex LAMTOR2/LAMTOR3 and Their Association with Breast Cancer Risk
por: De Araujo, Mariana E., et al.
Publicado: (2013) -
LAMTOR1 degrades MHC-II via the endocytic in hepatocellular carcinoma
por: Wu, Bo, et al.
Publicado: (2022) -
The TCL1A Oncoprotein Interacts Directly with the NF-κB Inhibitor IκB
por: Ropars, Virginie, et al.
Publicado: (2009) -
Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCε-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression
por: Chen, Yunzhao, et al.
Publicado: (2019)